Caxton Associates (New York)
HCAT icon

Caxton Associates (New York)’s Health Catalyst HCAT Stock Holding History

Caxton Associates (New York)’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,773
Closed -$157K – 553
2022
Q4 		$157K Buy
+14,773
New +$143K 0.01% 398
2021
Q3 		– Sell
-5,098
Closed -$283K – 505
2021
Q2 		$283K Buy
+5,098
New +$272K 0.03% 330

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Caxton Associates (New York)'s HCAT Position: Q1 2023 in Review

Caxton Associates (New York) sold out of Health Catalyst (HCAT) in Q1 2023, closing a stake of 14,773 shares — an estimated $157K sold.

Caxton Associates (New York) first reported a position in HCAT in Q2 2021 and held it in 2 quarters. The position peaked at $283K in Q2 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q1 2023.

  • Caxton Associates (New York) reported no remaining Health Catalyst position as of Q1 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 14,773 Health Catalyst shares in Q1 2023, an estimated $157K.
  • Caxton Associates (New York) first reported a position in Health Catalyst in Q2 2021 and held it in 2 quarters.
  • Caxton Associates (New York)'s Health Catalyst position peaked at $283K in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2023.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.